文献速递神经肿瘤

微创后外侧经海绵窦-经小脑幕入路治疗蝶岩斜脑膜瘤

The Minimally Invasive Posterolateral Transcavernous-Transtentorial Approach. Technical Nuances, Proof of Feasibility, and Surgical Outcomes Throughout a Case Series of Sphenopetroclival Meningiomas.
PubMed 文献 · World Neurosurg · 2021-08-31

该病例系列纳入14例蝶岩斜脑膜瘤患者,采用改良微创翼点后外侧经海绵窦-经小脑幕入路(MIPLATTA)手术。11例(78%)获全切除,3例(22%)近全切除后补充乙状窦后入路完成全切除;无死亡,13例6个月随访时改良Rankin量表评分≤2。

要点

  • MIPLATTA可用于以海绵窦和中颅窝侵犯为主的大型蝶岩斜脑膜瘤
  • 14例中11例(78%)全切除,其余3例(22%)经补充乙状窦后入路完成全切除
  • 术后38条颅神经病变中15条(39%)改善、20条(53%)稳定、3条(8%)加重

核心结论

  • MIPLATTA是安全有效的治疗选择,可切除以海绵窦和中颅窝侵犯为主的大型蝶岩斜肿瘤,保留听力和面神经运动功能,并有望改善视觉与动眼神经缺损。

研究设计与样本

  • 单中心病例系列,14例蝶岩斜脑膜瘤患者经MIPLATTA手术治疗。
  • MIPLATTA包括小翼点开颅、前部硬膜外前床突切除、颞窝剥离、海绵窦内颅神经减压及小脑幕切开以到达后颅窝上部。

主要发现

  • 11/14例(78%)实现全切除,另3例(22%)近全切除后补充乙状窦后入路完成全切除。
  • 无死亡病例,14例中13例在6个月随访时独立(改良Rankin量表评分≤2)。
  • 1例术后发生脑桥梗死,随访时为中度残疾(改良Rankin量表评分3)。
  • 所有患者均存在一定程度颅神经损害;38条颅神经病变中15条(39%)改善、20条(53%)稳定、3条(8%)术后加重。
  • 3例患者术后出现4条新发颅神经缺损(第4颅神经2例、第3颅神经1例、第5颅神经1例)。

临床怎么用

  • 对于以海绵窦和中颅窝侵犯为主的大型蝶岩斜脑膜瘤,可考虑采用MIPLATTA以获得肿瘤切除并保留听力与面神经运动功能。
  • 术后需关注颅神经功能变化及脑桥梗死等并发症,部分颅神经缺损可恢复。

局限性

  • 为单中心小样本病例系列(14例),缺乏对照组,结论需更大样本研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Sphenopetroclival (SPC) meningiomas are considered among the most complex skull-base neoplasms to approach surgically. We aim to determine whether some SPC meningiomas can be safely and effectively treated using a modified minimally invasive pterional posterolateral transcavernous-transtentorial approach (MIPLATTA). METHODS: Fourteen patients harboring SPC meningiomas were surgically treated through a MIPLATTA. MIPLATTA includes a minipterional craniotomy, anterior extradural clinoidectomy, peeling of the temporal fossa, decompression of cranial nerves (CNs) in the cavernous sinus, and sectioning of the tentorium to reach the upper part of the posterior fossa. RESULTS: Gross total resection was achieved in 11 of 14 patients (78%), whereas near-total resection was accomplished in the other 3 patients (22%), each of whom underwent a further complementary retrosigmoid approach for gross total tumor resection. There were no deaths, and 13 of 14 patients were independent at 6 months follow-up (modified Rankin Scale score ≤2). One patient had pontine infarction after the procedure and experienced moderate disability at follow-up (modified Rankin Scale score 3). All patients had some degree of CN impairment. Of 38 cranial neuropathies, 15 (39%) improved, 20 (53%) remained stable, and 3 (8%) worsened postoperatively. Four new CN deficits were observed postoperatively in 3 patients (fourth CN, 2 patients; third CN, 1; fifth CN, 1). CONCLUSIONS: MIPLATTA is a useful and safe treatment alternative that allows resection of large SPC tumors with dominant invasion of cavernous sinus and middle fossa, preserves hearing and facial motor function, and provides good chances of recovery of visual and oculomotor deficits.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Martínez-Pérez R, Tsimpas A, Marin-Contreras F, et al. The Minimally Invasive Posterolateral Transcavernous-Transtentorial Approach. Technical Nuances, Proof of Feasibility, and Surgical Outcomes Throughout a Case Series of Sphenopetroclival Meningiomas. World Neurosurg. 2021. PMID: 34478889. doi:10.1016/j.wneu.2021.08.108

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。